GO
Loading...

Geron Corp

More

  • Pops & Drops: Geron, Wells Fargo... Monday, 9 Mar 2009 | 6:32 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Geron and Wells Fargo popped while HSBC and Proctor & Gamble dropped.

  • Obama's First 100 Days: What He's Done So Far Monday, 9 Mar 2009 | 1:29 PM ET

    President Barack Obama lifted restrictions on federal funding of human embryonic stem cell research Monday, angering abortion opponents but cheering those who believe the study could produce treatments for many diseases.

  • Stem Cell Summit Tuesday, 17 Feb 2009 | 6:38 PM ET

    Which firms are racing to the forefront of this bold new science?

  • Stem Cells Sell Tuesday, 17 Feb 2009 | 1:45 PM ET

    Attendance at the 4th Annual Stem Cell Summit is up, by about 50 percent, no less, over last year. All day long privately-held and publicly-traded companies are presenting to around 250 investors.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Cramer makes the call on viewers' favorite stocks.

  • Pops & Drops: Morgan Stanley, Playboy... Friday, 23 Jan 2009 | 6:22 PM ET

    Following are the week’s biggest winners and losers. Find out why shares of Morgan Stanley and Geron popped while Playboy and Wal-Mart dropped.

  • The Politics And Science Of Geron Friday, 23 Jan 2009 | 2:57 PM ET
    Geron

    A few days into his term, President Obama appears to have begun to undo another Bush-era policy. He hasn't yet formally lifted the Bush-imposed ban on federal funding of new embryonic stem cell research, but Obama's Food and Drug Administration has already set the stage for it.

  • Antigenics Finds That "Russian Roulette" Pays Off Tuesday, 8 Apr 2008 | 10:31 AM ET

    This morning a little biotech company, Antigenics, announced that Russia has approved its kidney cancer drug Oncophage. It's the first so-called therapeutic cancer vaccine to win full-out approval anywhere in the world.

  • Stem Cell Trade Back On? Friday, 21 Sep 2007 | 11:12 AM ET

    Is the stem cell trade back on, ahead of next week’s biotech conference? The traders talk how to play stem cells without investing in risky, small biotech companies.

  • It's Time for the Lightning Round! Wednesday, 23 May 2007 | 6:39 PM ET

    Saks, BP, RadioShack and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • No. 2 - Bio-Hazard Monday, 14 May 2007 | 1:08 PM ET

    Sometimes the stocks that trade on hope lead only to despair. Investors in biotech companies Amgen (AMGN) and Dendreon (DNDN) suffered serious side effects this week as the FDA raised questions about the safety and effectiveness of their flagship drugs. Is there any hope for a sector that trades on hope?

  • It's Time for the Lightning Round! Thursday, 5 Apr 2007 | 9:42 PM ET

    Saks, Acadia Pharma, Geron, Harley Davidson, Walgreen and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.